NovaBay Pharma: Soars as EPA approves antimicrobial solution against SARS-CoV-2

Stablecoin Development

14/12/2020 12:29

** Biopharma co's shares  NBY.A  surge 31.2% to $90 cents
premarket 
    ** Co announces its proprietary hypochlorous acid solution
has received U.S. Environmental Protection Agency (EPA) approval
for a kill claim against SARS-CoV-2, the virus that causes
COVID-19  urn:newsml:reuters.com:*:nBw24kstxa
    ** Approval follows third-party laboratory results in July
showing effectiveness of the antimicrobial spray
    ** The solution has been found to safely eliminate 99.9% of
viruses and bacteria on nonporous hard surfaces 
    ** Up to Friday's close, stock up ~7% YTD

 (Reporting by Shivani Kumaresan in Bengaluru)
 ((Shivani.Kumaresan@thomsonreuters.com ; +1 646 223 8780))